ACERTAPHARMA
Acerta Pharma is focused on the development of covalent binding technology solutions to create therapies for cancer. Acerta Pharma was acquired by AstraZeneca in February 2016. Acerta Pharma was founded in 2013 and is based in San Carlos, California.
ACERTAPHARMA
Social Links:
Industry:
Biotechnology Oncology Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.acerta-pharma.com
Total Employee:
51+
Status:
Active
Contact:
650-591-2800
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Amazon ASP.NET IIS IIS 10 ReCAPTCHA V3 ASP.NET Ajax New Relic Comcast Telerik Controls Visual Studio
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Founder
Investors List
BOM
BOM investment in Series A - AcertaPharma
BioGeneration Ventures
BioGeneration Ventures investment in Series A - AcertaPharma
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - AcertaPharma
Official Site Inspections
http://www.acerta-pharma.com Semrush global rank: 8.09 M Semrush visits lastest month: 654
- Host name: server-99-84-208-16.iad79.r.cloudfront.net
- IP address: 99.84.208.16
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "AcertaPharma"
About Us | Acerta Pharma - A Member of the AstraZeneca Group
Acerta Pharma began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced dedicated team in order to deliver novel …See details»
AcertaPharma - Crunchbase Company Profile & Funding
Acerta Pharma is focused on the development of covalent binding technology solutions to create therapies for cancer. Acerta Pharma was acquired by AstraZeneca in February 2016. Acerta Pharma was founded in 2013 and is …See details»
Acerta Pharma B.V. - The Org
Acerta Pharma is a leader in the field of covalent binding technology who is applying this technology to create novel, highly selective therapies for cancer. Industries. Pharmaceutical. …See details»
Organization | Acerta Pharma
Acerta Pharma Report issue Contributed to NME For profit Phase 1 Phase 2 Phase 3 Founded: San Carlos CA United States (2013)See details»
What We Do | Acerta Pharma - A Member of the AstraZeneca Group
Acerta Pharma, in close collaboration with research groups in AstraZeneca, takes an innovative approach to discover, ... The AstraZeneca and Acerta research organization has deep …See details»
Acerta Pharma LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Acerta Pharma LLC of Redwood City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Acerta Pharma - Overview, News & Similar companies - ZoomInfo
May 10, 2019 AstraZeneca Presents Clinical Research Advances for Blood Cancer Patients at 2018 American Society of Hematology Annual Meeting WILMINGTON, Del.--(BUSINESS …See details»
Acerta Pharma Company Profile - Office Locations, Competitors
Acerta Pharma is a biopharmaceutical company. It specializes in the field of covalent binding technology. The company aims to provide therapies for the treatment of cancer and …See details»
AcertaPharma - Funding, Financials, Valuation & Investors
Acerta Pharma provides drug discovery and development services for oncology and autoimmune diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Acerta Pharma | BioGeneration Ventures
Within one year from inception, Acerta Pharma entered into clinical trials and presented compelling clinical results by the end of 2015. AstraZeneca acquired a 55% stake in the Company in a deal with an overall value over $7 billion. …See details»
Acerta Pharma CEO and Key Executive Team | Craft.co
Acerta Pharma's Chief Scientific Officer is Andrew Mortlock. Other executives include Mark Fisher, Vice President, R&D Oncology Unit; Mauricio Flores, Sr. Director, Head of Finance and …See details»
AstraZeneca completes transaction for majority equity stake …
Feb 2, 2016 About Acerta Pharma. Acerta is a leader in the field of covalent binding technology and is applying this technology to create novel selective therapies intended for the treatment of …See details»
Acerta Pharma - Wikipedia
Acerta Pharma B.V. werd in 2012 opgericht door Allard Kaptein en Tjeerd Barf. De twee waren werkzaam bij Organon.Het bedrijf ontwikkelt medicijnen ter bestrijding van kanker, maar heeft …See details»
AstraZeneca buys most of Acerta for $4 billion to add cancer drug
Dec 17, 2015 AstraZeneca is to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of blood cancer drug, boosting its long-term growth at …See details»
AcertaPharma - Contacts, Employees, Board Members, Advisors
Acerta Pharma provides drug discovery and development services for oncology and autoimmune diseases.See details»
Careers - Acerta Pharma
At Acerta Pharma we’re passionate about a more sustainable working environment. We've grown a lot in recent years and we're doing much more research. That means a bigger environmental …See details»
Acerta Pharma BV
了解Acerta Pharma BV (Acerta Pharma BV)公司的药物管线，治疗领域，技术平台，以及它的63项临床试验, 47篇新闻和22篇文献，疾病领域:免疫系统疾病，血液及淋巴系统疾病，肿瘤， …See details»
Our-Pipeline | Acerta Pharma - A Member of the AstraZeneca Group
Working together, Acerta and AstraZeneca are focused on Innovative Clinical Strategies to enable us to combine our extensive oncology portfolio of cancer therapies as well as combinations …See details»
アストラゼネカ、ACERTA PHARMAへの投資によりオンコロジー …
Dec 18, 2015 Acerta Pharmaについて Acerta社は共有結合技術分野のリーダーであり、本技術をがんおよび自己免疫疾患の治療薬を目的とする新規かつ選択的治療薬の創製に適用してい …See details»